Your browser doesn't support javascript.
loading
Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer.
Nøst, Therese Haugdahl; Skogholt, Anne Heidi; Urbarova, Ilona; Mjelle, Robin; Paulsen, Erna-Elise; Dønnem, Tom; Andersen, Sigve; Markaki, Maria; Røe, Oluf Dimitri; Johansson, Mikael; Johansson, Mattias; Grønberg, Bjørn Henning; Sandanger, Torkjel Manning; Saetrom, Pål.
Afiliación
  • Nøst TH; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Skogholt AH; Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
  • Urbarova I; Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
  • Mjelle R; Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Paulsen EE; Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
  • Dønnem T; Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
  • Andersen S; Bioinformatics Core Facility, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
  • Markaki M; Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Røe OD; Department of Pulmonology, University Hospital of North Norway, Tromsø, Norway.
  • Johansson M; Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Johansson M; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
  • Grønberg BH; Department of Clinical Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
  • Sandanger TM; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.
  • Saetrom P; Institute of Computer Science, Crete, Greece.
Mol Oncol ; 17(2): 312-327, 2023 02.
Article en En | MEDLINE | ID: mdl-36337027
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: MicroARNs / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Noruega